The CDC is offering a grant to support the continuation of a birth defects surveillance system in main hospitals in Kampala, Uganda. This project focuses on external structural birth defects and aims to assess the correlation between maternal use of certain medications during early pregnancy and the risk of birth defects in newborns. The results will establish baseline rates of birth defects and maternal medication use for HIV treatment during pregnancy. The findings will guide WHO and PEPFAR on the use of specific HIV medications in pregnant women.
Opportunity ID: 331881
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-GH21-2160 |
| Funding Opportunity Title: | Hospital Based Birth Defects Surveillance in Kampala, Uganda under the President’s Emergency Plan for AIDS Relief (PEPFAR) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.067 — Global AIDS |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 4 |
| Posted Date: | Mar 04, 2021 |
| Last Updated Date: | Mar 25, 2021 |
| Original Closing Date for Applications: | May 04, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Current Closing Date for Applications: | May 04, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | – |
| Estimated Total Program Funding: | $0 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Eligible applicants that can apply for this NOFO are:Makerere University-Johns Hopkins University Research Collaboration (MU-JHU) |
Additional Information
| Agency Name: | Centers for Disease Control – CGH |
| Description: | The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $1,000,000 for Year 1, subject to the availability of funds.This NOFO aims to: 1) continue a birth defects surveillance system in at least four main hospitals in Kampala, Uganda focusing on major external structural birth defects; and 2) determine if maternal use of dolutegravir, cotrimoxazole or other medications during very early pregnancy is associated with a higher risk of birth defects in newborns. Results from these activities will provide background rates of birth defects in Kampala, provide baseline estimates of maternal medication use to treat HIV in pregnancy, and ascertain any correlation between medication use and external birth defects. WHO and PEPFAR will use these findings to inform guidance regarding use of specific HIV medications during pregnancy. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Emily Dale
dln6@cdc.gov Email:dln6@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Due to an update in our application packages on Grants.gov, if you retrieved a package before today March 24, 2021, you will have to retrieve an updated application package with the new versions of the updated forms. If you have any questions please contact ogstims@cdc.gov. |
Mar 25, 2021 | |
| Administrative Amendment | Mar 04, 2021 | |
| Amended NOFO. | Mar 04, 2021 | |
| Mar 04, 2021 |
DISPLAYING: Synopsis 4
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-GH21-2160 |
| Funding Opportunity Title: | Hospital Based Birth Defects Surveillance in Kampala, Uganda under the President’s Emergency Plan for AIDS Relief (PEPFAR) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.067 — Global AIDS |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 4 |
| Posted Date: | Mar 04, 2021 |
| Last Updated Date: | Mar 25, 2021 |
| Original Closing Date for Applications: | May 04, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Current Closing Date for Applications: | May 04, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | – |
| Estimated Total Program Funding: | $0 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Eligible applicants that can apply for this NOFO are:Makerere University-Johns Hopkins University Research Collaboration (MU-JHU) |
Additional Information
| Agency Name: | Centers for Disease Control – CGH |
| Description: | The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $1,000,000 for Year 1, subject to the availability of funds.This NOFO aims to: 1) continue a birth defects surveillance system in at least four main hospitals in Kampala, Uganda focusing on major external structural birth defects; and 2) determine if maternal use of dolutegravir, cotrimoxazole or other medications during very early pregnancy is associated with a higher risk of birth defects in newborns. Results from these activities will provide background rates of birth defects in Kampala, provide baseline estimates of maternal medication use to treat HIV in pregnancy, and ascertain any correlation between medication use and external birth defects. WHO and PEPFAR will use these findings to inform guidance regarding use of specific HIV medications during pregnancy. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Emily Dale
dln6@cdc.gov Email:dln6@cdc.gov |
DISPLAYING: Synopsis 3
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-GH21-2160 |
| Funding Opportunity Title: | Hospital Based Birth Defects Surveillance in Kampala, Uganda under the President’s Emergency Plan for AIDS Relief (PEPFAR) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.067 — Global AIDS |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 3 |
| Posted Date: | Mar 04, 2021 |
| Last Updated Date: | Mar 23, 2021 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | May 04, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | – |
| Estimated Total Program Funding: | $0 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Eligible applicants that can apply for this NOFO are:
Makerere University-Johns Hopkins University Research Collaboration (MU-JHU) |
Additional Information
| Agency Name: | Centers for Disease Control – CGH |
| Description: | The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $1,000,000 for Year 1, subject to the availability of funds. This NOFO aims to: 1) continue a birth defects surveillance system in at least four main hospitals in Kampala, Uganda focusing on major external structural birth defects; and 2) determine if maternal use of dolutegravir, cotrimoxazole or other medications during very early pregnancy is associated with a higher risk of birth defects in newborns. Results from these activities will provide background rates of birth defects in Kampala, provide baseline estimates of maternal medication use to treat HIV in pregnancy, and ascertain any correlation between medication use and external birth defects. WHO and PEPFAR will use these findings to inform guidance regarding use of specific HIV medications during pregnancy. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Emily Dale
dln6@cdc.gov Email:dln6@cdc.gov |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-GH21-2160 |
| Funding Opportunity Title: | Hospital Based Birth Defects Surveillance in Kampala, Uganda under the President’s Emergency Plan for AIDS Relief (PEPFAR) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.067 — Global AIDS |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Mar 04, 2021 |
| Last Updated Date: | Mar 11, 2021 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | May 04, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | – |
| Estimated Total Program Funding: | $0 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Eligible applicants that can apply for this NOFO are:
Makerere University-Johns Hopkins University Research Collaboration (MU-JHU) |
Additional Information
| Agency Name: | Centers for Disease Control – CGH |
| Description: | The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $1,000,000 for Year 1, subject to the availability of funds. This NOFO aims to: 1) continue a birth defects surveillance system in at least four main hospitals in Kampala, Uganda focusing on major external structural birth defects; and 2) determine if maternal use of dolutegravir, cotrimoxazole or other medications during very early pregnancy is associated with a higher risk of birth defects in newborns. Results from these activities will provide background rates of birth defects in Kampala, provide baseline estimates of maternal medication use to treat HIV in pregnancy, and ascertain any correlation between medication use and external birth defects. WHO and PEPFAR will use these findings to inform guidance regarding use of specific HIV medications during pregnancy. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Emily Dale
dln6@cdc.gov Email:dln6@cdc.gov |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | CDC-RFA-GH21-2160 |
| Funding Opportunity Title: | Hospital Based Birth Defects Surveillance in Kampala, Uganda under the President’s Emergency Plan for AIDS Relief (PEPFAR) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.067 — Global AIDS |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 04, 2021 |
| Last Updated Date: | Mar 04, 2021 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | May 04, 2021 Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date. |
| Archive Date: | – |
| Estimated Total Program Funding: | $0 |
| Award Ceiling: | $0 |
| Award Floor: | $0 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Eligible applicants that can apply for this NOFO are:
Makerere University-Johns Hopkins University Research Collaboration (MU-JHU) |
Additional Information
| Agency Name: | Centers for Disease Control – CGH |
| Description: | The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $1,000,000 for Year 1, subject to the availability of funds. This NOFO aims to: 1) continue a birth defects surveillance system in at least four main hospitals in Kampala, Uganda focusing on major external structural birth defects; and 2) determine if maternal use of dolutegravir, cotrimoxazole or other medications during very early pregnancy is associated with a higher risk of birth defects in newborns. Results from these activities will provide background rates of birth defects in Kampala, provide baseline estimates of maternal medication use to treat HIV in pregnancy, and ascertain any correlation between medication use and external birth defects. WHO and PEPFAR will use these findings to inform guidance regarding use of specific HIV medications during pregnancy. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Emily Dale
dln6@cdc.gov Email:dln6@cdc.gov |
Related Documents
Folder 331881 Full Announcement-Full Announcement -> NOFO for CDC-RFA-GH21-2160.pdf
Folder 331881 Revised Full Announcement-Revised Full Announcement -> Amended NOFO for CDC-RFA-GH21-2160.pdf
Packages
| Agency Contact Information: | Emily Dale dln6@cdc.gov Email: dln6@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.067 | CDC-RFA-GH21-2160 | Hospital Based Birth Defects Surveillance in Kampala, Uganda under the President’s Emergency Plan for AIDS Relief (PEPFAR) | PKG00265788 | Nov 18, 2020 | May 04, 2021 | View |
Package 1
Mandatory forms
331881 SF424_3_0-3.0.pdf
331881 Project_AbstractSummary_2_0-2.0.pdf
331881 SFLLL_2_0-2.0.pdf
331881 SF424A-1.0.pdf
331881 BudgetNarrativeAttachments_1_2-1.2.pdf
331881 ProjectNarrativeAttachments_1_2-1.2.pdf
Optional forms
331881 OtherNarrativeAttachments_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
